Stay updated on CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial
Sign up to get notified when there's something new on the CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial page.

Latest updates to the CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial page
- Check3 days agoChange DetectedA site-wide NIH banner announces a transition from using “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434 and links to updates and FAQs.SummaryDifference1%

- Check10 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 on the ClinicalTrials.gov 403 error page.SummaryDifference0.2%

- Check17 days agoChange DetectedThe site footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check37 days agoChange DetectedThe page now shows a new Revision: v3.7.0. A large set of key study documents and links, including the Informed Consent Form (ICF), Statistical Analysis Plan (SAP), Study Protocol, and IPD sharing information, were removed.SummaryDifference24%

- Check59 days agoChange DetectedPage revision label updated to v3.6.6, representing a small metadata version update. This does not change the substantive study details displayed on the page.SummaryDifference0.0%

- Check80 days agoChange DetectedThe page's revision label was updated from v3.6.4 to v3.6.5, indicating a minor backend/content management update has been applied. This change reflects a version bump rather than a substantive alteration to the publicly displayed content.SummaryDifference0.0%

Stay in the know with updates to CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial page.